Plain-English translation of NCT07670416 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Obesity research guide โPhase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called enicepatide to help people lose weight and manage their blood sugar. The medication is given as an injection once a week. Researchers want to see if it works better than a placebo (a fake injection) when combined with diet and exercise changes.
Many people struggle to lose weight and manage blood sugar with diet and exercise alone. This medication is designed to help control appetite and improve blood sugar control, so researchers are testing whether it could be a helpful new treatment option for people dealing with weight and diabetes challenges.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will receive either the new medication or a placebo injection once per week for several months. You'll visit the research clinic regularly for check-ins, blood tests, and weight measurements. You'll also be asked to follow a reduced-calorie diet and exercise plan, and keep track of how you're feeling. The researchers will monitor you closely to make sure the treatment is safe and working.
AI-generated summary from trial data ยท Jul 16, 2026 ยท Not medical advice
China